Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Sus Scrofa Placenta is a complex biological extract classified as a Non-Standardized Allergenic Extract, containing natural estrogens, androgens, and adrenergic agonists used in specialized therapeutic contexts.
Name
Sus Scrofa Placenta
Raw Name
SUS SCROFA PLACENTA
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
30
Variant Count
30
Last Verified
February 17, 2026
About Sus Scrofa Placenta
Sus Scrofa Placenta is a complex biological extract classified as a Non-Standardized Allergenic Extract, containing natural estrogens, androgens, and adrenergic agonists used in specialized therapeutic contexts.
Detailed information about Sus Scrofa Placenta
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Placenta.
Sus Scrofa Placenta refers to the processed extract derived from the placenta of the domestic pig (Sus scrofa). In the landscape of modern pharmacology, it is classified primarily as a Non-Standardized Plant Allergenic Extract [EPC], though its biological complexity allows it to fall under several other Established Pharmacologic Classes (EPC), including Estrogen [EPC], Progesterone [EPC], and Androgen [EPC]. This substance is a biological cocktail containing a myriad of bioactive compounds, including growth factors, cytokines, amino acids, and steroid hormones. Historically, porcine-derived tissues have been utilized in organotherapy and traditional medicine systems, but contemporary clinical use focuses on its role in allergenic desensitization and its potential influence on the endocrine and immune systems.
Sus Scrofa Placenta belongs to a class of drugs called biological extracts or non-standardized allergenic extracts. Unlike purified single-molecule drugs (such as lisinopril or atorvastatin), this extract contains a wide spectrum of porcine-derived proteins and hormones. The FDA historically categorizes such substances under the regulatory framework of allergenic extracts or homeopathic pharmacopeia (HPUS), depending on the specific preparation and intended use. While it is not a 'first-line' pharmaceutical in conventional internal medicine, it remains a subject of significant clinical interest in regenerative medicine and endocrinology due to its high homology with human placental tissue.
The mechanism of action for Sus Scrofa Placenta is multi-faceted and involves the activation of several distinct receptor systems. At the molecular level, the extract contains endogenous steroid hormones that act as Estrogen Receptor Agonists [MoA] and Androgen Receptor Agonists [MoA]. When these molecules enter the systemic circulation, they bind to intracellular receptors (ER-alpha, ER-beta, and AR), translocating to the nucleus to modulate gene expression related to tissue repair, secondary sexual characteristics, and metabolic rate.
Furthermore, the extract exhibits activity as Adrenergic alpha-Agonists [MoA] and Adrenergic beta-Agonists [MoA]. This is attributed to the presence of catecholamines and related trace amines within the placental matrix. These compounds interact with G-protein coupled receptors (GPCRs) on various tissues, potentially influencing vascular tone and metabolic activity. The presence of growth factors, such as Epidermal Growth Factor (EGF) and Transforming Growth Factor-beta (TGF-β), suggests a paracrine signaling mechanism that promotes cellular proliferation and extracellular matrix remodeling.
Understanding the pharmacokinetics of a complex biological extract like Sus Scrofa Placenta is challenging because each component possesses its own kinetic profile. However, general clinical observations provide the following framework:
Sus Scrofa Placenta is utilized in several clinical contexts, though many uses are considered 'non-standardized' or based on historical clinical data:
Sus Scrofa Placenta is available in several formulations, often dictated by the specific therapeutic goal:
> Important: Only your healthcare provider can determine if Sus Scrofa Placenta is right for your specific condition. Because this is a biological product, the risk of variability between batches is higher than with synthetic medications.
Dosage for Sus Scrofa Placenta is not standardized across the pharmaceutical industry, as it often depends on the concentration of the extract and the specific manufacturer’s protocol. However, general clinical guidelines suggest the following ranges for adults:
Sus Scrofa Placenta is generally not recommended for pediatric use unless specifically directed by a specialist in pediatric endocrinology or immunology. The presence of active steroid hormones (estrogens and androgens) poses a significant risk to the developing endocrine system in children, potentially leading to premature epiphyseal closure (stunting of growth) or precocious puberty. If a healthcare provider deems it necessary for allergenic desensitization, the dose will be calculated based on body surface area and strictly monitored.
Patients with significant renal impairment (CrCl < 30 mL/min) should use Sus Scrofa Placenta with caution. While the primary proteins are metabolized by peptidases, the nitrogenous waste from protein breakdown and the metabolites of steroid hormones require renal excretion. Dose reductions of 25–50% may be necessary to prevent accumulation.
Because the liver is the primary site for the metabolism of the estrogenic and androgenic components of Sus Scrofa Placenta, patients with hepatic cirrhosis or elevated transaminases may experience prolonged half-lives of these hormones. Close monitoring of liver function tests (LFTs) is required, and the drug should be discontinued if jaundice or significant enzyme elevation occurs.
Geriatric patients often have a higher sensitivity to hormonal shifts and adrenergic agonists. In patients over 65, lower starting doses are recommended to minimize the risk of cardiovascular strain (due to adrenergic effects) or fluid retention (due to estrogenic effects).
If you miss a dose of Sus Scrofa Placenta, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one, as this increases the risk of acute hormonal or adrenergic side effects.
Signs of an acute overdose of Sus Scrofa Placenta may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on cardiovascular stability and symptom management.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or stop taking this medication without medical guidance, especially if being used for hormonal regulation.
Because Sus Scrofa Placenta contains active hormonal and adrenergic components, side effects are relatively common, particularly during the initiation phase of therapy. Patients frequently report:
> Warning: Stop taking Sus Scrofa Placenta and call your doctor immediately if you experience any of these serious symptoms:
Prolonged use of Sus Scrofa Placenta (exceeding 6 months) may lead to:
Currently, there are no FDA-mandated black box warnings specifically for 'Sus Scrofa Placenta' as a standalone ingredient. However, because it contains active Estrogens and Androgens, healthcare providers must consider the class-wide warnings associated with these hormones, including the increased risk of endometrial cancer, cardiovascular disease, and deep vein thrombosis (DVT) in postmenopausal women.
Report any unusual symptoms to your healthcare provider immediately to ensure your safety while using this biological product.
Sus Scrofa Placenta is a complex biological product derived from animal tissue. It is not a purified pharmaceutical, and its use carries inherent risks related to biological variability and the presence of multiple active pharmacological classes. Patients must be aware that this extract can influence the endocrine, cardiovascular, and immune systems simultaneously.
No FDA black box warnings for Sus Scrofa Placenta exist at this time. However, the extract's constituents (estrogens and androgens) are subject to class-wide safety concerns regarding thromboembolic events and hormone-sensitive malignancies. Healthcare providers should apply the same level of scrutiny to Sus Scrofa Placenta as they would to conventional Hormone Replacement Therapy (HRT).
As a Non-Standardized Animal Skin/Plant/Food Allergenic Extract [EPC], Sus Scrofa Placenta contains foreign porcine proteins. Individuals with known allergies to pork or porcine-derived products (such as certain types of insulin or heparin) are at a significantly higher risk for anaphylaxis. A skin prick test may be recommended before initiating systemic therapy.
Patients taking Sus Scrofa Placenta for more than 30 days should undergo the following monitoring:
Sus Scrofa Placenta may cause dizziness, tremors, or changes in blood pressure due to its adrenergic effects. Patients should observe their reaction to the medication for at least 48 hours before driving or operating heavy machinery. If you experience palpitations or 'jitters,' avoid these activities.
Alcohol should be avoided or strictly limited while taking Sus Scrofa Placenta. Alcohol can exacerbate the hepatic load and may increase the risk of estrogen-related side effects by altering the way the liver metabolizes steroid hormones. Furthermore, alcohol can worsen the cardiovascular effects of adrenergic agonists.
Do not stop taking Sus Scrofa Placenta abruptly if you have been using it for a prolonged period. Sudden discontinuation can lead to a 'hormonal crash,' characterized by extreme fatigue, mood swings, and vasomotor symptoms (hot flashes). A tapering schedule, supervised by a healthcare provider, is recommended to allow the endogenous endocrine system to resume normal function.
> Important: Discuss all your medical conditions, especially any history of blood clots or cancer, with your healthcare provider before starting Sus Scrofa Placenta.
Sus Scrofa Placenta should NEVER be used in combination with the following:
Sus Scrofa Placenta may interfere with the following laboratory results:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Provide a full list of any animal-derived supplements you use.
Sus Scrofa Placenta must NEVER be used in patients with the following conditions:
Conditions requiring a careful risk-benefit analysis by a healthcare provider:
Patients who are allergic to the following substances may also react to Sus Scrofa Placenta:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of allergic reactions to medications or foods, before prescribing Sus Scrofa Placenta.
Sus Scrofa Placenta is Contraindicated during pregnancy. The extract contains a potent mix of estrogens, progesterones, and androgens that can disrupt the delicate hormonal balance required to maintain a healthy pregnancy. Exposure to exogenous androgens during pregnancy can cause virilization of a female fetus, while exogenous estrogens may interfere with fetal endocrine development. According to the principles of teratogenicity, any substance that acts on steroid receptors should be avoided unless the benefits clearly outweigh the substantial risks, which is rarely the case for this extract.
It is not known whether the specific bioactive peptides and growth factors in Sus Scrofa Placenta pass into human breast milk. However, steroid hormones are known to be excreted in milk and can potentially affect the nursing infant, leading to symptoms like breast enlargement or hormonal imbalances. Additionally, the adrenergic components may cause irritability or sleep disturbances in the infant. Breastfeeding is generally not recommended while using this medication.
Sus Scrofa Placenta is not approved for use in children. The primary concern is the presence of Androgen [EPC] and Estrogen [EPC] constituents, which can cause premature closure of the epiphyseal growth plates in the long bones, leading to permanent short stature. It may also trigger precocious puberty. Its use in children is restricted solely to specialized allergenic desensitization protocols under the strict supervision of a pediatric allergist.
Clinical data suggest that elderly patients are at an increased risk for adverse effects from Sus Scrofa Placenta. Specifically:
Lower doses and frequent monitoring are mandatory for patients over the age of 65.
In patients with moderate to severe renal impairment, the excretion of nitrogenous byproducts from the placental proteins and the conjugated metabolites of the steroid hormones is impaired. This can lead to uremic symptoms or exaggerated hormonal effects. Patients with a GFR < 45 mL/min should have their dose reduced by at least 50%.
Sus Scrofa Placenta should be avoided in patients with Child-Pugh Class B or C hepatic impairment. The liver's inability to conjugate and clear estrogens and androgens can lead to rapid toxicity, including the development of peliosis hepatis or worsening of portal hypertension.
> Important: Special populations require individualized medical assessment. Always inform your specialist if you fall into any of these categories before beginning treatment.
Sus Scrofa Placenta operates through a multi-pathway biological mechanism. Its primary action is mediated through Estrogen Receptor Agonists [MoA] and Androgen Receptor Agonists [MoA]. Upon administration, the steroid ligands dissociate from their carrier proteins and diffuse across the cell membrane. They bind to their respective nuclear receptors, causing a conformational change that allows the receptor-ligand complex to bind to Hormone Response Elements (HREs) on DNA. This initiates the transcription of mRNA, leading to the synthesis of proteins that regulate everything from cell cycle progression to metabolic rate.
Additionally, the extract functions as an Adrenergic alpha-Agonist and beta-Agonist. It stimulates alpha-1 receptors on vascular smooth muscle (causing vasoconstriction) and beta-1 receptors on the myocardium (increasing heart rate and contractility). The presence of Adrenocorticotropic Hormone [EPC] and l-Thyroxine [EPC] suggests secondary involvement in the HPA axis and thyroid regulation, although these effects are typically less pronounced than the primary steroid and adrenergic actions.
The pharmacodynamic effect of Sus Scrofa Placenta is characterized by a slow onset of hormonal action (days to weeks for genomic effects) but a rapid onset of adrenergic action (minutes to hours for non-genomic effects). Dose-response relationships are non-linear due to the complex feedback loops of the endocrine system. Tolerance may develop to the adrenergic effects over time, whereas the hormonal effects may become more pronounced as systemic levels reach a steady state.
| Parameter | Value |
|---|---|
| Bioavailability | 15–30% (Oral); 80–90% (Injection) |
| Protein Binding | 95–98% (primarily SHBG and Albumin) |
| Half-life | 4–12 hours (component dependent) |
| Tmax | 1–3 hours (Oral) |
| Metabolism | Hepatic (CYP3A4, CYP1A2, Glucuronidation) |
| Excretion | Renal (70%), Fecal (30%) |
Sus Scrofa Placenta is categorized as a Non-Standardized Animal Skin/Plant/Food Allergenic Extract [EPC]. Related medications include other glandular extracts (such as bovine adrenal or thyroid extracts) and standardized hormonal therapies (such as conjugated estrogens or testosterone cypionate).
Common questions about Sus Scrofa Placenta
Sus Scrofa Placenta is primarily used as a non-standardized biological extract for various therapeutic purposes, including allergenic desensitization and endocrine support. It contains natural porcine-derived hormones like estrogens and androgens, which healthcare providers may use to address hormonal imbalances in specific integrative medicine protocols. Additionally, it is utilized in some dermatological applications to promote skin repair and rejuvenation due to its growth factor content. Because it is a complex biological product, it is also studied for its immunomodulatory effects in chronic conditions. Always consult a healthcare professional to determine if this specific extract is appropriate for your clinical needs.
The most common side effects of Sus Scrofa Placenta involve gastrointestinal issues and hormonal shifts. Patients frequently report mild nausea, bloating, or abdominal discomfort shortly after taking the supplement. Because the extract contains active estrogens and androgens, women may notice breast tenderness or changes in their menstrual cycle, while men might experience nipple sensitivity. Other frequent reports include mild headaches and a sense of 'jitteriness' or increased heart rate, which is attributed to the adrenergic components of the extract. These symptoms often diminish as the body acclimates to the treatment over several weeks.
It is strongly advised to avoid or significantly limit alcohol consumption while taking Sus Scrofa Placenta. Alcohol can place additional strain on the liver, which is already working to metabolize the complex steroid hormones found in the placental extract. This competition for hepatic enzymes can lead to higher-than-intended levels of estrogen in the blood, increasing the risk of side effects like blood clots or mood swings. Furthermore, alcohol can worsen the cardiovascular effects of the adrenergic agonists in the extract, potentially leading to palpitations or high blood pressure. For your safety, discuss your alcohol intake with your doctor before starting this medication.
No, Sus Scrofa Placenta is considered unsafe for use during pregnancy and is generally contraindicated. The extract contains active androgens and estrogens that can cross the placental barrier and interfere with the normal hormonal development of the fetus. Exposure to these exogenous hormones can lead to developmental abnormalities or virilization of a female fetus. Furthermore, the placental extract could potentially trigger uterine contractions or disrupt the mother's natural hormonal balance required to maintain the pregnancy. If you are pregnant or planning to become pregnant, you should not use this product.
The time it takes for Sus Scrofa Placenta to show results depends on the condition being treated and the specific formulation used. The adrenergic effects, such as increased energy or changes in heart rate, can often be felt within a few hours of administration. However, the hormonal and immunomodulatory effects typically take much longer to manifest, often requiring 4 to 8 weeks of consistent use to reach a steady state in the body. For dermatological or wound-healing purposes, visible changes in skin texture may take several weeks of daily application. Your healthcare provider will monitor your progress to determine the efficacy of the treatment.
Stopping Sus Scrofa Placenta suddenly is not recommended, especially if you have been taking it for an extended period. Because the extract provides exogenous hormones, your body's natural endocrine production may have slowed down in response. Abruptly withdrawing the extract can lead to a 'hormonal crash,' resulting in symptoms such as extreme fatigue, depression, anxiety, and physical weakness. It is much safer to work with your healthcare provider to gradually taper the dose over several weeks. This allows your adrenal and sex glands to slowly resume their normal production levels.
If you miss a dose of Sus Scrofa Placenta, you should take it as soon as you remember, provided it is not too close to your next scheduled dose. If you are within a few hours of your next dose, simply skip the missed one and continue with your regular schedule. Never take two doses at once to make up for a missed one, as this can lead to an acute spike in hormone levels or heart rate. Keeping a consistent level of the extract in your system is important for its effectiveness, so consider using a pill organizer or phone alarm. If you miss multiple doses, contact your doctor for advice on how to restart.
Sus Scrofa Placenta can cause weight changes in some individuals, primarily due to its hormonal constituents. The estrogenic components may lead to fluid retention and bloating, which can appear as a sudden increase in scale weight. On the other hand, the androgenic and adrenergic components might slightly increase metabolic rate, which could theoretically support weight loss in some contexts. However, most patients who report weight gain find it is related to 'water weight' rather than actual fat mass. If you notice significant or rapid weight gain while taking this extract, you should consult your healthcare provider to check for edema or other metabolic changes.
Sus Scrofa Placenta has a high potential for drug interactions because it affects multiple systems in the body. It should not be taken with other hormonal treatments, such as birth control pills or HRT, without strict medical supervision, as this can lead to dangerously high hormone levels. It may also interact with blood pressure medications, blood thinners like warfarin, and medications for diabetes. Because it contains adrenergic agonists, it can be dangerous when combined with certain antidepressants like MAOIs. Always provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are currently taking.
Sus Scrofa Placenta is not available as a 'generic' in the traditional sense because it is a complex biological extract rather than a synthetic chemical drug. Instead, it is sold under various brand names and by different manufacturers of glandular supplements or homeopathic remedies. The quality, concentration, and purity can vary significantly between different products. When purchasing, it is important to choose a reputable manufacturer that follows Good Manufacturing Practices (GMP). Your healthcare provider can recommend a specific brand or formulation that has been tested for consistency and safety.